Abstract:AIM:To study the transfection and anti-hepatitis B virus (HBV) effect of the co-modified hepatocytes-targeting cationic liposomes encapsulating anti-HBV antisense oligonucleotides (asON) , and to investigate the transfection mechanisms of the liposomes.METHODS:Dipalmitoylphosphatidylcholine (DPPC) and 3beta-[N-(N',N'-dimethylaminoethane)-carbamoyl] cholesterol (DC-Chol) were used as the lipids, beta-sitosterol-beta-D-glucoside (sito-G) and Brij 35 were used to modify the liposomes. Flow cytometry (FCM), fluorescence microscopy and enzyme-linked immunosorbent assay (ELISA) were utilized to evaluate the transfection improvement of the asON encapsulated in the liposomes in primary rat hepatocytes and the antigens inhibition activity in HepG 2.2.15 cells. The transfection mechanisms were evaluated based on the influence of wortmannin, nigericin, and asialofetuin on the antigens inhibition in HepG 2.2.15 cells by ELISA.RESULTS:The co-modification with sito-G and Brij 35 significantly improved the transfection of the liposomes in primary rat hepatocytes and antigens inhibition effect in HepG 2.2.15 cells. Both transfection efficiency and antigens inhibition effect showed to be concentration-dependent with the asON-encapsulating liposomes. In fluorescence microscopy, the transfected cells showed strong fluorescence in primary rat hepatocytes, especially in the nuclei. Wortmannin, nigericin and asialofetuin decreased the antigens inhibition of the asON-encapsulating liposomes to different levels. Cationic liposomes modification with sito-G and Brij 35 could improve the transfection and antigens inhibition effect of the asON. The transfection mechanisms of the co-modified liposomes included endocytosis and membrane fusion. The ligand sito-G was confirmed to be able to enhance asialoglycoprotein receptor (ASGPR)-mediated endocytosis.CONCLUSION:Co-modified hepatocytes-targeting cationic liposomes would be a specific and effective carrier to transfer asON into hepatocytes.

Mechanisms of co-modified liver-targeting liposomes as gene delivery carriers based on cellular uptake and antigens inhibition effect.

[Transfection and Anti-Hbv Effect Mediated by the Hepatocytes-Targeting Cationic Liposomes Co-Modified with Beta-Sitosterol-beta-d-glucoside and Brij 35].

Characteristics and Biodistribution of Soybean Sterylglucoside and Polyethylene Glycol-Modified Cationic Liposomes and Their Complexes with Antisense Oligodeoxynucleotide

Hepatocytes targeting of cationic liposomes modified with soybean sterylglucoside and polyethylene glycol

Preparation and Biological Property Evaluation of Novel Cationic Lipid-Based Liposomes for Efficient Gene Delivery

Hepatocyte-targeting and Microenvironmentally Responsive Glycolipid-Like Polymer Micelles for Gene Therapy of Hepatitis B.

Optimized Cationic Lipid-assisted Nanoparticle for Delivering CpG Oligodeoxynucleotides to Treat Hepatitis B Virus Infection

Enhanced Hepatic Delivery of Sirna and Microrna Using Oleic Acid Based Lipid Nanoparticle Formulations

[Cationic liposomes enhance the inhibitory effects of antisense oligodeoxynucleotide on hepatitis B virus].

[Liver Targeting of Cationic Liposomes Modified with Soybean-Derived Sterylglucoside in Vitro].

Liver-Targeted Delivery of Oligonucleotides with N-Acetylgalactosamine Conjugation

Multifunctional Oligomer Incorporation: a Potent Strategy to Enhance the Transfection Activity of Poly(l-Lysine)

Targeted gene delivery to hepatoma cells using galactosylated liposome-polycation-DNA complexes (LPD).

Targeting delivery of oligonucleotide and plasmid DNA to hepatocyte via galactosylated chitosan vector.

Gene delivery into hepatocytes with the preS/liposome/DNA system.

Novel Synthetic LPDs Consisting of Different Cholesterol Derivatives for Gene Transfer into Hepatocytes.

Redox-responsive Chitosan Oligosaccharide-Ss-octadecylamine Polymeric Carrier for Efficient Anti-Hepatitis B Virus Gene Therapy.

[Biodistribution and Hepatocytes Targeting of Cationic Liposomes Surface-Modified with Sterylglucoside and Golyethylene Glycol].

596. Incorporation of a Hepatocyte-Specific Compound in Polycationic Liposomes Enhances Gene Transfection in Hep G2 Cells

N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver

Hepatic-targeted Gene Delivery Using Cationic Mannan Vehicle.